百奥泰生物科技（广州）有限公司（Biothera Solutions, formerly as Sinoasis Pharma, Ltd.）致力于研究开发新型完全人源抗体或其衍生多肽药物，专注于用于治疗危及人类生命的重大疾病,包括癌症，心血管疾病。公司专有的人源抗体或功能域的筛选技术和高效抗体生产表达技术，能够快速地将基因组信息转换成完全人源的抗体治疗药物，从而大大提高抗体药物的发现和开发的效率。通过几年的努力，公司已有丰富的在研产品线，其中一个候选药已进入临床后期。 公司在由香港科技园承办的生物创业投资论坛会中荣获”最具潜力公司” （http://www.chinabiotoday.com/articles/20090504_2）。 由于发展需要，公司现增加多个挑战性的岗位，欢迎符合条件的有志者加盟。
Biothera Solutions Ltd (formerly as Sinoasis Pharma), an emerging biotechnology company in Guangzhou, China, is dedicated to researching and developing novel therapeutics for the treatment of cancers, cardiovascular diseases, and other life threatening diseases. The Company\'s initial internal products are focused on targets with relative degree of validation and disease areas with proven market opportunities, the areas of cancers and coronary heart diseases, the leading causes of death in both China and developed countries. The Company has developed a suite of proprietary therapeutic antibody engineering and production technologies, including a highly efficient antibody production system in CHO cells in a scalable fed-batch culture environment. Our fully human antibody technology platforms are well positioned to not only develop therapeutics internally but also provide services for biotech and pharmaceutical companies, including antibody manufacturing in a cGMP complied facility. Today, with one candidate product in late stage clinical and several in research with great potential, there remains a lot of challenging tasks to be accomplished and rewarding opportunities for energetic individuals to join our team. Biothera Solutions provides a competitive benefit package.
公司网站：
